THRD
Third Harmonic Bio Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$242.79M
P/E Ratio
—
EPS
$-1.24
Beta
2.13
52W High
$5.53
52W Low
$5.13
50-Day MA
$5.40
200-Day MA
$6.51
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Third Harmonic Bio Inc.
Third Harmonic Bio Inc. is a pioneering biotechnology firm focused on creating breakthrough therapies for severe immunology and inflammation-related disorders. Leveraging its proprietary genetic engineering platform, the company is developing a promising pipeline of drug candidates designed to meet critical unmet medical needs in the biopharmaceutical industry. With an unwavering dedication to scientific innovation and improving patient outcomes, Third Harmonic Bio is poised to significantly influence the treatment landscape, offering transformative solutions for patients enduring complex health challenges.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-64.25M |
| Operating Margin | 0.00% |
| Return on Equity | -19.90% |
| Return on Assets | -14.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.06 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $45.13M |
| Float | $15.60M |
| % Insiders | 9.11% |
| % Institutions | 80.12% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
58.7%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026